SCHEMBL4948948

SCHEMBL4948948

Cc1cc(Br)cc(C)c1OCC(=O)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
FAAH O00519 2/20 0.42
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
OPRL1 P41146 1/20 0.42
HTR1A P08908 4/20 0.41
HTR2A P28223 4/20 0.41
HTR7 P34969 4/20 0.41
HTR6 P50406 4/20 0.41
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
GPR183 P32249 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
BACE1 P56817 1/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948705 0.90 OPRM1 (0.45) NPSR1OPRM1OPRK1OPRL1HTR1A
SCHEMBL4953406 0.85 HTR1A (0.46) OPRM1OPRK1OPRL1HTR1AHTR2A
SCHEMBL13996781 0.84 RAB9A (0.58) ALDH1A1HPGDOPRM1OPRK1OPRL1
SCHEMBL4948806 0.83 MEN1 (0.50) ALDH1A1OPRM1OPRK1OPRL1HTR1A
SCHEMBL4953715 0.83 MAPT (0.54) ALDH1A1NPSR1OPRM1OPRK1OPRL1
SCHEMBL4948679 0.83 MEN1 (0.44) HPGDNPSR1OPRM1OPRK1OPRL1
SCHEMBL4951481 0.82 CYP2D6 (0.45) ALDH1A1OPRM1OPRK1OPRL1HTR1A
SCHEMBL4954789 0.81 OPRM1 (0.45) ALDH1A1HPGDOPRM1OPRK1OPRL1
SCHEMBL4953313 0.81 HTR1A (0.49) OPRM1OPRK1OPRL1HTR1AHTR2A
SCHEMBL4952253 0.81 OPRM1 (0.45) ALDH1A1HPGDOPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 ALDH1A1 119/4885HPGD 226/4885NPSR1 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.